60% cancer patients need psychological support for emotional distress: Doctors
BENGALURU: As many as 60% of cancer patients suffer from severe emotional distress and need professional psychological support, experts highlighted at a round table discussion on psycho-oncology on Wednesday.
Health Minister Dinesh Gundu Rao said the government is open to exploring ways to integrate psychosocial support into government hospitals, despite cancer treatment falling under the purview of the medical education department.
The round table -- Integrating Psychosocial Care into Mainstream Cancer Management -- was organised by Healthcare Global Enterprises Ltd (HCG) and the Centre of Psycho-oncology for Education and Research (COPER). Doctors and psychologists emphasised that cancer care must go beyond just physical treatment to include structured emotional and psychological support.
Dr Brindha Sitaram, Group Director of Psycho-oncology Services at HCG and Founder-Director of COPER, said 52% of cancer patients in India suffer from moderate to severe psychological distress, while 40% face mild emotional distress. She also said cancer patients are four times more likely to die by suicide than the general population, and that cancer-related suicides in India have increased by 50% between 1997 and 2020.
The minister said psycho-social care plays a crucial role in helping patients and their families cope with the disease, improving communication with doctors and eventually contributing to better treatment outcomes.
Sharing a personal experience, he said his father had died of Acute Myeloid Leukemia (AML) when he was 22, and he had seen firsthand the emotional toll the disease takes. He stressed that every hospital should have at least one clinical psychologist.
Health experts proposed that emotional wellbeing be recognised as the 'sixth vital sign' in cancer care, in addition to heart rate, respiration, temperature, blood pressure and pain. They called for regular screening for distress, immediate intervention and mandatory training of doctors and care providers to identify psychological needs.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
a day ago
- New Indian Express
Stampeding crowd ideal for Covid surge; against state's own advisory
BENGALURU: While the Chinnaswamy Stadium tragedy that claimed 11 young lives is shocking, another possible tragedy may be in waiting — a massive surge in Covid-19 cases in Bengaluru. The lakhs-strong gatherings on Wednesday — of about 1 lakh in front of Vidhana Soudha — for the felicitation of the IPL 2025 champions Royal Challengers Bengaluru (RCB) team — and about 3 lakhs around M Chinnaswamy Stadium who were trying to attend the celebrations inside the stadium — were in complete contradiction to the Covid Appropriate Behaviour (CAB) advisory that the Karnataka government itself had issued on May 23, even as the cases were rising. Incidentally, on Wednesday, the fateful day when the large gatherings led to the fatal stampede, the Health and Family Welfare Department reported a massive jump in the number of Covid cases from 53 to 153, while the positivity rate was 25.8% and the case fatality rate was 1.3%. The state has recorded seven deaths so far in the latest Covid surge as of Thursday. The state health department issued a clear advisory on May 23, warning of a steady rise in Covid cases. The advisory had urged the public to strictly follow CAB, especially in crowded places. Vulnerable groups were specifically advised to wear masks. It also recommended hand hygiene and use of sanitizers. And yet, the government that issued this warning went on to organise one of the largest mass gatherings just days later at the felicitation on the grand steps of Vidhana Soudha — with no safety measures. Although the advisory had called for caution, the State Government itself threw that very caution to the winds. The teeming crowds near Chinnaswamy Stadium featured no distancing, masking, or health protocols in place, while doctors and medical experts explained that such gatherings create 'vulnerable clusters' which contributes to the Covid infection surges. When The New Indian Express questioned Karnataka Health Minister Dinesh Gundu Rao about this, he said there are currently no mandatory protocols in place for masking or crowd control, except for those who are immunocompromised. 'Even the Government of India hasn't issued any specific restrictions at this point. If you look at it that way, every cricket match is a large gathering — and there are no curbs on such events right now,' Rao said.
Business Standard
2 days ago
- Business Standard
Servier India introduces 'Ivosidenib'(Tibsovo®), in India, First-in-class Targeted Therapy in Oncology for Rare IDH1-Mutated AML and Cholangiocarcinoma
VMPL Mumbai (Maharashtra) [India], June 5: Servier India, a subsidiary of the leading French pharmaceutical Servier Group, today announced the launch of Ivosidenib (Tibsovo®), an oral targeted therapy approved in the management of cancer patients with Acute Myeloid Leukemia (AML) and Cholangiocarcinoma, with an isocitrate dehydrogenase-1 (IDH1) mutation. Servier India received the approval on 14th May 2025, from Central Drugs Standard Control Organisation (CDSCO) for the import, sale, and distribution of the medication. Acute myeloid leukemia is a challenging hematological malignancy. Studies indicate that only about 30-40% of AML patients in India receive adequate treatment1, with high mortality rates due to rapid disease progression and infections. Cholangiocarcinomas (CCA) are rare tumours originating from bile duct. Due to their asymptomatic nature they are usually diagnosed when the disease is advanced.2 The announcement marks a significant advancement in management of the mentioned rare and difficult-to-treat cancers in India, addressing a critical unmet medical need. Speaking on the occasion, Mr. Aurelien Breton, Managing Director, Servier India, said, "Our focus is to advance oncology care by bringing innovative, precision medicines to patients who need them the most. By prioritizing access and working to make treatment options affordable to patients, we are dedicated to bridging critical gaps in cancer care across the country. This launch is a significant step forward in our mission to support healthcare providers with targeted treatment options and ultimately improve survival outcomes and quality of life for patients throughout India." IDH1 mutation occurs in approximately 7-14% of AML patients in India3, making targeted mechanisms especially relevant for this subset. "This therapy represents a significant therapeutic option in the treatment of AML and Cholangiocarcinoma. For healthcare professionals, this precision therapy offers a new, effective option that can improve patient outcomes where traditional treatments have limited success. It highlights the benefits of targeted therapy and caliber of innovation in enhancing lives and advancing cancer care in India.", highlighted Dr. Pranav Sopory, Medical and Patient Affairs Director, Servier India. Speaking on the importance of treatment access, Ms. Pratima Tripathi, Commercial Director, Servier India, said: "Our foremost priority is to ensure that the therapy is accessible and affordable to patients across India. We are actively collaborating with healthcare providers, patient advocacy groups, and policymakers to remove barriers and facilitate timely access to this important therapy. Through these partnerships, we are committed to expanding treatment options and making a meaningful difference in the lives of patients." By introducing these advanced therapies, Servier India reaffirms its commitment to advancing innovative cancer treatments that improve clinical outcomes and enhance the quality of life of patients. Disclaimer: This press release is intended solely to share regulatory and medical information regarding the launch; the reference to "Tibsovo" is not intended as a promotional or public advertisement. Use of the therapy is strictly based on a doctor's prescription and clinical discretion. About Servier India Servier India has been committed for over three decades to delivering innovative pharmaceutical solutions that improve the lives of patients and their families across India. Established in 1985 as an affiliate of the leading independent French pharmaceutical Servier Group, the company focuses on therapeutic areas such as Cardiometabolism, Neuroscience, Venous Diseases, and Oncology. Servier India has a strong pan-India presence and a dedicated workforce of around 580 that strives to address critical healthcare challenges with passion and purpose. As part of Servier group operating in over 150 countries, Servier India inherits a rich legacy of scientific excellence and patient-centric innovation. Globally, Servier invests heavily in research and development, focusing on our key therapeutic areas. About Servier Servier is a global pharmaceutical group governed by a Foundation that aspires to serve its vocation with a long-term vision: being committed to therapeutic progress to serve patient needs. As a world leader in cardiometabolism and venous diseases, Servier's ambition is to become a focused and innovative player in oncology by targeting rare cancers. Headquartered in France, Servier relies on a strong geographical footprint; its medicines are available in close to 140 group achieved a revenue of EUR5.9 billion in 2024. Additional Details on Ivosidenib Internationally, Ivosidenib has already received regulatory approvals in more than 42 countries, including the USA, Europe, China, UAE, and South Korea. In the United States, the US FDA approved it in 2019 as a monotherapy and later in May 2022 as a combination treatment with Azacitidine for patients aged 75 and above, or those who cannot tolerate intensive chemotherapy. The European Medical Agency (EMA) gave its approval in May 2023 for use in patients who are not fit for standard induction chemotherapy. In India, the process moved forward in April 2025, when the Subject Expert Committee (SEC) gave a positive recommendation for Ivosidenib. Following this, the DCGI granted approval for the marketing authorization in May 2025
Time of India
3 days ago
- Time of India
Youth can change things because of new ideas and opportunities: DGR
Mangaluru: Today's youth can change things because of their new ideas, thoughts, and new ways of doing things, said district minister Dinesh Gundu Rao. Rao was addressing 750 youths from nearly 10 countries, who are part of the three-day 'Global Youth Summit 2025', an international conference that started on Wednesday. The first-of-its-kind conference is hosted by the State NSS Cell, department of youth empowerment and sports, govt of Karnataka, in collaboration with Yenepoya (Deemed to be University). He said that the conference is focusing on the issues concerning the youth, the challenges that the youth are facing today, and the issues that they are confronting. "There are so many things happening around the world. Whether it is in Africa, Asia, Europe, or America, every country has controversial issues as well as many interesting developments. For the youth today, there are definitely a lot of opportunities for them to learn and grow," he noted. The minister asked youths to think and take action on how they can cut across barriers to bring in solidarity. "All must come together, and it is about solidarity. It is how we can bring people together, how we can think in a way that benefits not only ourselves but also the world," he said. He asked the youth to focus on and raise discussions about environmental civil rights, transgender rights, women's empowerment, human rights, and women's rights. "In many countries, political movements and democracies are in danger, with authoritarian regimes taking over," he said. During his address, the minister also highlighted growing health concerns among youth, linking lifestyle choices in a digitised world to rising instances of diabetes, blood pressure, mental stress, and other ailments. "Health issues among youngsters are concerning. It is due to lifestyle, and we see the onset of so many diseases. Concentration levels are going down, and there are poor communication skills. Youth are suffering from mental stress. All need to take care of their mental and physical health," he told the participants.
